LH — Labcorp Holdings Balance Sheet
0.000.00%
- $23.76bn
 - $28.78bn
 - $13.01bn
 
- 93
 - 47
 - 88
 - 90
 
Annual balance sheet for Labcorp Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,321 | 1,473 | 430 | 537 | 1,519 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,017 | 2,978 | 3,017 | 2,099 | 2,097 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,125 | 5,331 | 4,625 | 3,765 | 4,807 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,809 | 2,897 | 3,031 | 2,981 | 3,045 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,072 | 20,385 | 20,155 | 16,725 | 18,379 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,079 | 2,783 | 3,079 | 3,225 | 3,330 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,712 | 10,112 | 10,059 | 8,850 | 10,327 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9,360 | 10,273 | 10,097 | 7,875 | 8,052 | 
| Total Liabilities & Shareholders' Equity | 20,072 | 20,385 | 20,155 | 16,725 | 18,379 | 
| Total Common Shares Outstanding |